Skip Navigation

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Blomer, U.
Right arrow Articles by Gage, F. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blomer, U.
Right arrow Articles by Gage, F. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 5, 1397-1404, Copyright © 1996 by Oxford University Press

REVIEWS

Applications of gene therapy to the CNS

U Blomer, L Naldini, IM Verma, D Trono and FH Gage
Salk Institute for Biological Studies, La Jolla, CA 92037-1099, USA.

Gene therapy is a new method with potential for treating a broad range of acquired and inherited neurologic diseases, where the causative gene defect or deletion has been identified. In addition to gene replacement the application of gene products that reduce cellular dysfunction or death represent new therapeutic options. Gene transfer techniques to express novel proteins using different viral vectors in vitro and in vivo, as well as animal models and human trials will be reviewed in this article. We will focus on a new lentiviral vector as a recent gene transfer method and degenerative disorders of the CNS, and their related model systems.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Philippe, C. Sarkis, M. Barkats, H. Mammeri, C. Ladroue, C. Petit, J. Mallet, and C. Serguera
Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo
PNAS, November 21, 2006; 103(47): 17684 - 17689.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
C. Crozet, Y.-L. Lin, C. Mettling, C. Mourton-Gilles, P. Corbeau, S. Lehmann, and V. Perrier
Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations
J. Cell Sci., November 1, 2004; 117(23): 5591 - 5597.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
H. Nadeau and H. A. Lester
NRSF Causes cAMP-Sensitive Suppression of Sodium Current in Cultured Hippocampal Neurons
J Neurophysiol, July 1, 2002; 88(1): 409 - 421.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. S. Gambhir, J. R. Barrio, M. E. Phelps, M. Iyer, M. Namavari, N. Satyamurthy, L. Wu, L. A. Green, E. Bauer, D. C. MacLaren, et al.
Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography
PNAS, March 2, 1999; 96(5): 2333 - 2338.
[Abstract] [Full Text] [PDF]

Home page
 Br J OphthalmolHome page
A. F WRIGHT
Gene therapy for the eye
Br J Ophthalmol, August 1, 1997; 81(8): 620 - 622.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.